Share this article
LONDON and NEW YORK, April 14, 2021 /PRNewswire/ Huma, Europe s fastest-growing health technology company
1, is partnering with the non-profit patient advocacy group RARE-X, which runs a collaborative patient-powered data collection platform for global data sharing and analysis to accelerate treatments for rare disease.
RARE-X s federated data platform will pair with Huma s decentralized clinical trials platform, complete with remote monitoring and digital biomarkers. Together, they will work closely with researchers, drug developers, and patient communities to gather data from anywhere in the world and make it easier for patients and their families to share data with researchers.
Nicole Boice, Founder and CEO of RARE-X, said:
(1)
LONDON and NEW YORK, March 11, 2021 /PRNewswire/ Huma s exponential growth in healthcare and lifesciences across Europe has been recognised by the
Financial Times. Huma is leading healthcare and life sciences expansion with four national deals for its hospital at home digital wards (Germany, England, Wales, UAE).
Across all sectors, Huma has been selected as the 23rd fastest-growing company in Europe
[1], on the published list of 1,000. The London-based start-up provides a modular remote monitoring platform to run digital hospitals at home . This technology also powers research in the US and across Europe, including some of the world s largest decentralized clinical trials on illnesses ranging from atrial fibrillation to diabetes to Covid-19.